{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T00:19:11Z","timestamp":1789258751615,"version":"build-2803163510"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T00:00:00Z","timestamp":1602547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002975","name":"Dainippon Sumitomo Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002975","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jiac.2020.10.005","type":"journal-article","created":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T08:18:02Z","timestamp":1603527482000},"page":"277-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["A real-world prospective observational study on the efficacy and safety of liposomal amphotericin B in 426 patients with persistent neutropenia and fever"],"prefix":"10.1016","volume":"27","author":[{"given":"Minoru","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Masaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5598-5845","authenticated-orcid":false,"given":"Eiji","family":"Nakajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2020.10.005_bib1","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJM199903113401004","article-title":"Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia","volume":"340","author":"Walsh","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2020.10.005_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJM200201243460403","article-title":"Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever","volume":"346","author":"Walsh","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2020.10.005_bib3","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1056\/NEJMoa040446","article-title":"Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia","volume":"351","author":"Walsh","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2020.10.005_bib4","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2020.10.005_bib5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3314\/mmj.54.147","article-title":"JSMM clinical practice guidelines for diagnosis and treatment of invasive candidiasis 2013","volume":"54","author":"The Japanese Society for Medical Mycology","year":"2013","journal-title":"Med Mycol J"},{"key":"10.1016\/j.jiac.2020.10.005_bib6","series-title":"JSMM clinical practice guidelines for diagnosis and treatment of aspergillosis 2015","author":"The Japanese Society for Medical Mycology","year":"2015"},{"key":"10.1016\/j.jiac.2020.10.005_bib7","doi-asserted-by":"crossref","first-page":"E117","DOI":"10.3314\/mmj.16-00010","article-title":"Executive summary of Japanese domestic guidelines for management of deep-seated mycosis 2014","volume":"57","author":"Kohno","year":"2016","journal-title":"Med Mycol J"},{"key":"10.1016\/j.jiac.2020.10.005_bib8","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2020.10.005_bib9","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"Suppl.7","key":"10.1016\/j.jiac.2020.10.005_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/1469-0691.12041","article-title":"ESCMID\u2217 guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)","volume":"18","author":"Ullmann","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2020.10.005_bib11","first-page":"3515","article-title":"Management of infection during chemotherapy for acute leukemia in Japan: a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group","volume":"25","author":"Kimura","year":"2017","journal-title":"Support Care Canc"},{"key":"10.1016\/j.jiac.2020.10.005_bib12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1600-0609.2010.01410.x","article-title":"Fatal Trichosporon fungemia in patients with hematologic malignancies","volume":"84","author":"Suzuki","year":"2010","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jiac.2020.10.005_bib13","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.3389\/fmicb.2016.01629","article-title":"Invasive Trichosporon infection: a systematic review on a re-emerging fungal pathogen","volume":"7","author":"de Almeida J\u00fanior","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jiac.2020.10.005_bib14","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/imj.12598","article-title":"Consensus guidelines for the treatment of invasive mould infections in haematological malignancy and haemopoietic stem cell transplantation, 2014","volume":"44","author":"Blyth","year":"2014","journal-title":"Intern Med J"},{"key":"10.1016\/j.jiac.2020.10.005_bib15","doi-asserted-by":"crossref","first-page":"a019737","DOI":"10.1101\/cshperspect.a019737","article-title":"Treatment principles for the management of mold infections","volume":"5","author":"Kontoyiannis","year":"2014","journal-title":"Cold Spring Harb Perspect Med"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X20303640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X20303640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:02:35Z","timestamp":1761159755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X20303640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1341321X20303640"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2020.10.005","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A real-world prospective observational study on the efficacy and safety of liposomal amphotericin B in 426 patients with persistent neutropenia and fever","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2020.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}